stockrowInsulet Corporation
PODD Healthcare Medical Devices
Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024.
- Revenue
- +19.2%
- EPS
- +64.1%
- Free cash flow
- −29.8%
- Total debt
- −5.19%
Quarter to September 2026, against a year earlier
Follow PODD
Alert me
Insulet Corporation (PODD) Operating margin
Insulet Corporation's operating margin over the twelve months to 30 September 2026 was 18.4%, up 0.9 percentage points from fiscal 2025 (17.5%). Over the past ten years it has ranged from −18.5% (fiscal 2015) to 17.5% (fiscal 2025) — the current reading is the highest in ten years. That is above the Medical Devices industry median of −15.1% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 17.5% | 2.59 |
| FY2024 | 14.9% | 1.94 |
| FY2023 | 13.0% | 10.09 |
| FY2022 | 2.88% | (8.59) |
| FY2021 | 11.5% | 5.78 |
| FY2020 | 5.69% | (1.08) |
| FY2019 | 6.77% | 1.91 |
| FY2018 | 4.86% | 6.46 |
| FY2017 | −1.60% | 1.32 |
| FY2016 | −2.92% | 15.55 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 22.5% | 6.36 |
| Jun 2026 | 16.2% | 0.15 |
| Mar 2026 | 16.0% | (2.63) |
| Dec 2025 | 18.7% | 2.00 |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| GMED Globus Medical, Inc. compare | 21.7% |
| PODD Insulet Corporation | 18.4% |
| PEN Penumbra, Inc. compare | 12.1% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| BRKR Bruker Corporation compare | −1.99% |
| BIO.B Bio-Rad Laboratories, Inc. compare | −2.39% |
| BIO Bio-Rad Laboratories, Inc. compare | −2.39% |
| TXG 10x Genomics compare | −14.3% |
| GKOS Glaukos Corporation compare | −25.5% |
| Medical Devices industry median | −15.1% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on PODD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement